Table 3.
Time-Dependent Covariate | Effect of Time-Dependent Covariate* | Treatment Group Adjusted for Time-Dependent Covariate* |
||
---|---|---|---|---|
Hazard Ratio (95% CI) |
P Value | Hazard Ratio (95% CI) |
P Value | |
None | — | — | 0.53 (0.34-0.83) | 0.005 |
Renal disease (yes vs. no)† | 2.99 (0.72-12.5) | 0.20 | 0.54 (0.34-0.84) | 0.006 |
Microalbuminuria (yes vs. no)‡ | 2.93 (1.85-4.65) | <0.001 | 0.62 (0.39-0.97) | 0.04 |
Albuminuria (yes vs. no) § | 2.57 (1.36-4.88) | 0.009 | 0.58 (0.37-0.91) | 0.02 |
Mean glycosylated hemoglobin value¶ | ||||
Per 10% increase | 1.25 (1.10-1.43) | <0.001 | 0.84 (0.43-1.64) | 0.61 |
Per 10% decrease | 0.80 (0.70-0.91) | <0.001 |
All models were adjusted for the glycosylated hemoglobin value, age, cholesterol level, and smoking status at baseline in the DCCT.
Renal disease was defined by a serum creatinine level of at least 2 mg per deciliter, a history of kidney transplantation, or the implementation of dialysis.
Microalbuminuria was defined by a history of microalbuminuria or renal disease.
Albuminuria was defined by a history of albuminuria or renal disease.
The log mean glycosylated hemoglobin value was used so that the hazard ratio per c-fold change in risk is c2.26144, where 2.26144 is the estimated regression coefficient; a c of 1.1 corresponds to a 10 percent increase in the mean glycosylated hemoglobin value, and a c of 0.9 to a 10 percent decrease.